U.S. drops another $2.1B for doses of experimental coronavirus vaccine candidate
Pharma giants GlaxoSmithKline and Sanofi Pasteur announced Friday they will supply 100 million doses of an experimental COVID-19 vaccine to the United States.
from : World https://ift.tt/30jXn2r
from : World https://ift.tt/30jXn2r